Epidemiological study of metabolic syndrome in Brazilian soldiers

Abstract

Objective: The aim of this study was to carry out an epidemiological analysis of metabolic syndrome among Brazilian Army soldiers. Subjects and methods: Two thousand seven hundred and nineteen male soldiers of the Brazilian Army were evaluated from 2014 to 2016. Characteristics: age = 27.77 (± 8.59) years and BMI = 25.15 (± 3.41) kg/m 2. Blood tests and anthropometric measures were performed following the criteria of the International Diabetes Federation Task Force on MS Epidemiology and Prevention, 2009. The epidemiological analysis was based on Odds ratio (OR) with confidence interval (CI). Results: The prevalence of MS found was 12.21%. Both WC and BMI proved to be good predictors of changes in MS physiological markers. Increased WC and BMI were strongly associated with all physiological markers. Soldiers with WC ≥ 90 were more likely to present MS with OR = 33.37 (24.37-45.7). Soldiers with WC ≥ 90 also presented high risk of: high triglycerides with OR = 5.98 (4.69-7.61); low HLD-c with OR = 1.78 (1.47-2.16); and increased systolic blood pressure OR = 3.10 (2.55-3.76). Soldiers with BMI ≥ 30 had a high risk of: increased glucose with OR = 2.69 (1.93-3.75); and increased diastolic blood pressure with OR = 3.02 (2.22-4.10). Conclusion: Both WC and BMI can be considered as good predictors of changes in MS physiological markers. We believe that WC and BMI should be used as screening tools to indicate the soldiers that must undergo blood tests to monitor MS prevalence.

<p>Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk</p>

“…The multiple linear regression model was used to analyze the effect of covariables (criterion for MS) on ferritin values by the backward method. The coefficient of determination of the percentage of variation explained by the model was verified using R 2 . A logistic regression model was built to analyze the variables that contributed significantly to predict the outcome (hyperferritinemia) using the backward method.…”

“…Several definitions of MS have emerged over the years, showing, however, some variations concerning the criteria and reference values of the metabolic parameters involved. [1][2][3][4] There are several diagnostic consensuses for MS, but most include cardiometabolic risk factors, such as obesity, dyslipidemia, high blood pressure, insulin resistance, and pro-inflammatory state. The National Cholesterol Education Program ATP III criteria (NCEP ATP III) require the presence of any three of the following five conditions: abdominal obesity, hyperglycemia, low levels of HDL-c, high levels of serum triglycerides, and high blood pressure.…”

Adesão ao tratamento anti-hipertensivo e ocorrência de Síndrome Metabólica

“…MS is the most common metabolic change and has a growing prevalence worldwide. [9][10][11] In Brazil, this condition, evaluated from the harmonization of international consensus and secondary analysis of the 2013 National Health Survey, showed that 8.9% (IC99% 8.4-9.5) of the Brazilian population has MS. 12 Recent data from an epidemiological analysis show that in a specific Brazilian population the prevalence of MS found was 12.21%. 13 The Brazilian Society of Cardiology infers that MS is this association of several cardiovascular risk factors that associated, in turn, to SAH, under the epidemiological view, is responsible for an increase of up to 2.5 times in mortality from cardiovascular events.…”

Fatores de risco para síndrome metabólica em adultos jovens escolares

“…Neste contexto de DCNT, destaca-se a Síndrome Metabólica (SM) que em vista de seus elevados índices de prevalência mundial (Diaz, Espeche, March, Flores, Parodia, Genesio, Sabio, & Poppe, 2018;Assi, Ziv, & Dankner, 2019;Zhang, Qian, Sisi, Chuhao, & Hongzhuan, 2019), e que se estima, mesmo com escassez de dados epidemiológicos, a prevalência 8,9% nos brasileiros (Fortes, Rosa, Coutinho, & Neves, 2019), tornando-se um problema de grande magnitude, principalmente, devido à presença de resistência à insulina nas populações. O NCEP-ATP III coloca como necessário a presença de três entre cinco critérios para estabelecer o diagnóstico de SM.…”